Evidence map›Paper›PMID 32364126›Full record

ReviewNeurologia2020

Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey.

J Matías-Guiu, J A Matias-Guiu, J Alvarez-Sabin, J Ramon Ara, J Arenillas, I Casado-Naranjo, M Castellanos, M D Jimenez-Hernandez, J M Lainez-Andres, E Moral and 5 more

Abstract readReview
In one paragraph

Review in Neurologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Observational
  3. Neuropsychiatric Disorders and COVID-19: What We Know So Far.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

J Matías-GuiuServicio de Neurología, Hospital Clínico San Carlos, Madrid, España. Electronic address: neurol.hcsc@salud.madrid.
J A Matias-GuiuServicio de Neurología, Hospital Clínico San Carlos, Madrid, España.
J Alvarez-SabinServicio de Neurología, Hospital Universitario de Vall d'Hebron, Barcelona, España.
J Ramon AraServicio de Neurología, Hospital Miguel Servet, Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, España.
J ArenillasServicio de Neurología, Hospital Clínico de Valladolid, Valladolid, España.
I Casado-NaranjoServicio de Neurología, Complejo Hospitalario Universitario de Cáceres, Cáceres, España.
M CastellanosServicio de Neurología, Complejo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica A Coruña, A Coruña, España.
M D Jimenez-HernandezServicio de Neurología, Hospital Universitario Virgen del Rocío, Sevilla, España.
J M Lainez-AndresServicio de Neurología, Hospital Clínico Universitario de Valencia, Valencia, España.
E MoralHospital Moisès Broggi y Hospital General de l'Hospitalet, Barcelona, España.
A MoralesServicio de Neurología, Hospital Universitario Virgen de la Arrixaca, Murcia, España.
A Rodriguez-AntigüedadServicio de Neurología, Hospital Universitario de Cruces, Bilbao, España.
T SeguraServicio de Neurología, Hospital General Universitario de Albacete, Albacete, España.
P Serrano-CastroServicio de Neurología, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, España.
E Diez-TejedorServicio de Neurología, Hospital Universitario La Paz, Madrid, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe COVID-19 pandemic will give rise to long-term changes in neurological care, which are not easily predictable. MATERIAL AND

methodsA key informant survey was used to enquire about the changes expected in the specialty over the next 5 years. The survey was completed by heads of neurology departments with broad knowledge of the situation, having been active during the pandemic.

resultsDespite a low level of consensus between participants, there was strong (85%) and moderate consensus (70%) about certain subjects, mainly the increase in precautions to be taken, the use of telemedicine and teleconsultations, the reduction of care provided in in-person consultations to avoid the presence of large numbers of people in waiting rooms, the development of remote training solutions, and the changes in monitoring visits during clinical trials. There was consensus that there would be no changes to the indication of complementary testing or neurological examination.

conclusionThe key informant survey identified the foreseeable changes in neurological care after the pandemic.

Indexed as

Coronavirus InfectionsHealth Care SurveysNervous System DiseasesNeurologyPandemicsPneumonia, ViralAdministrative PersonnelClinical Laboratory TechniquesClinical Trials as TopicConsensus Statements as TopicCOVID-19COVID-19 TestingDisease ManagementDistance CounselingForecastingHospital DepartmentsAsistencia neurológicaConsensoConsensusCOVID-19Departamento de neurologíaGestión sanitariaHealthcare managementInformadores claveKey informantsNeurological careNeurology department

Identifiers

PMID32364126
PMCPMC7165283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.